Pieris Pharmaceuticals, Inc. (PIRS)
NASDAQ: PIRS · Real-Time Price · USD
17.07
+0.24 (1.43%)
Nov 5, 2024, 10:55 AM EST - Market open
Pieris Pharmaceuticals Employees
As of December 31, 2023, Pieris Pharmaceuticals had 50 total employees, including 46 full-time and 4 part-time employees. The number of employees decreased by 94 or -65.28% compared to the previous year.
Employees
50
Change (1Y)
-94
Growth (1Y)
-65.28%
Revenue / Employee
$417,440
Profits / Employee
-$476,360
Market Cap
22.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
Beyond Air | 107 |
PolyPid | 62 |
VSee Health | 40 |
Palatin Technologies | 30 |
Spruce Biosciences | 29 |
NeuroBo Pharmaceuticals | 8 |
XTL Biopharmaceuticals | 7 |
PIRS News
- 21 days ago - Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference - GlobeNewsWire
- 4 weeks ago - Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development to Support Phase 3 Single-Arm, Baseline-Controlled Trial in Microcystic Lymphatic Malformations - GlobeNewsWire
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of Shareholders - GlobeNewsWire
- 3 months ago - PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS - Business Wire
- 3 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Pieris Pharmaceuticals, Inc. - PRNewsWire
- 3 months ago - Dr. Vince Clinical Research Presents Groundbreaking Webinar on Accelerating Clinical & Drug Development Timelines with AI - Business Wire
- 3 months ago - Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement - Accesswire
- 7 months ago - Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split - Accesswire